Strengthening Inspiratory and Oropharyngeal Muscles in Moderate Obstructive Sleep Apnea Hypopnea Syndrome
REMI SAHOS
2 other identifiers
interventional
38
1 country
2
Brief Summary
The Obstructive Sleep Apnea hypopnea Syndrome (OSAS), whose prevalence is 4% of the French population, can lead to serious health consequences (risk of road accidents, onset of cardiovascular disease, etc.). OSAS corresponds to a certain number of interruptions (apneas) or reductions (hypopneas) of ventilation during sleep. The weakening of the tone of the inspiratory and oropharyngeal muscles is one of the main causes of upper airways obstruction during the inspiratory phase.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2024
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 18, 2024
CompletedFirst Posted
Study publicly available on registry
June 24, 2024
CompletedStudy Start
First participant enrolled
December 30, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
January 29, 2025
January 1, 2025
1.6 years
June 18, 2024
January 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Apnea-Hypopnea Index (AHI)
AHI is measured by polygraphy or polysomnography. It is not a score
At 3 months
Secondary Outcomes (7)
Maximum inspiratory pressure measurement (cmH2O)
At 3 and 9 Months
Neck circumference (cm)
At 3 months
Epworth sleepiness score
At 3 and 9 Months
Pittsburgh Sleep quality index
At 3 and 9 Months
Quality of life scale : Short Form 12 (SF12)
At 3 and 9 Months
- +2 more secondary outcomes
Study Arms (2)
Strengthening muscles group
EXPERIMENTALHome training to strengthen Inspiratory and Oropharyngeal muscles
No training group
NO INTERVENTIONNo intervention
Interventions
Patients will conduct the training at home, 5 days a week for 3 months. They will perform 2 sets of 30 inspirations against resistance (POWERbreathe® K5 , Powerbreathe International Limited, UK), equal to 70% Maximum Inspiratory Pressure (MIP). Patients will be guided for oropharyngeal exercises. The sessions will be supervised by the investigator every 3 weeks. During sessions with the investigator, sessions recorded in the device will be downloaded to verify compliance. A MIP measurement will be performed to adjust the resistance of the device.
Eligibility Criteria
You may qualify if:
- Moderate SAHOS (15 ≤ AHI ≤30);
- Body Mass Index (BMI) \< 35 ;
- Patient affiliated or entitled to a social security scheme;
- Patient having signed a consent to participate in the study.
You may not qualify if:
- Excessive daytime sleepiness: Epworth sleepiness score \> 10 ;
- Professional driving and history of accidents related to sleepiness;
- Severe obstructive or restrictive ventilatory disorders of neuromuscular origin authenticated by respiratory function tests;
- Patients undergoing treatment for OSAS or requiring immediate initiation of continuous positive airway pressure (CPAP) or a mandibular advancement orthosis;
- Patients who have stopped CPAP or orthosis treatment in less than one month;
- Patients undergoing cardiorespiratory exercise rehabilitation or starting regular physical training;
- Uncompensated heart failure, thoracic sternotomy surgery \< 4 months;
- Marked osteoporosis with history of rib fractures;
- History of spontaneous pneumothorax;
- Severe asthma;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
CHU de Grenoble
Grenoble, 38000, France
Centre Hospitalier Universitaire
Saint-Etienne, 42055, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amandine Zellag
CHU SAINT-ETIENNE
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 18, 2024
First Posted
June 24, 2024
Study Start
December 30, 2024
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
January 29, 2025
Record last verified: 2025-01